ASA: Adding Icosapent Ethyl to Statin Further Cuts Stroke Risk
Event rates for time to first fatal or nonfatal stroke significantly reduced for IPE versus placebo
One Year Into Pandemic, Biden Promises Vaccines for All U.S. Adults by May 1
Remarks came on the one-year anniversary of the WHO declaring COVID-19 to be a pandemic
Teplizumab Could Delay Diagnosis of Type 1 Diabetes
Teplizumab improves beta-cell function in high-risk individuals with relatives who have type 1 diabetes
Guidelines Provided for Unilateral Lymphadenopathy After COVID-19 Vaccination
In most clinical settings, ipsilateral UAL after recent COVID-19 vaccination is benign finding; clinical follow-up recommended
Prevalence of Vascular Risk Factors High for Hispanics/Latinos
Despite high awareness, secondary stroke prevention strategies are low
In Under 25s, Racial, Ethnic Disparities in COVID-19 Incidence Varied
Largest persistent disparities seen for NH/PI, AI/AN, and Hispanic or Latino persons from January to December 2020
Decline in Kidney Function Faster After COVID-19-Related AKI
Among patients who have in-hospital acute kidney injury, those with AKI tied to COVID-19 have faster rate of decrease in eGFR after discharge
Physical Activity May Improve Cardiorenal Outcomes in CKD
High physical activity level (7.5 to <15 MET hours/week) linked to lower risks for all-cause mortality, ESRD, MACE
Tocilizumab Use Not Supported for Moderate-to-Severe COVID-19
Progression of COVID-19 up to day 14 did not differ with addition of tocilizumab to standard care in Phase 3 trial conducted in India
One in Five Health Care Workers Reports Mental Health Conditions
Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic
